Samrat Pharmachem

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue59.0855.3460.1686.5171.12
Expenses55.0746.8950.1673.7863.02
EBITDA4.018.4510.0012.738.10
EBIT3.868.309.8512.577.94
Profit Before Tax3.878.569.9112.538.02
Net Profit2.796.456.999.375.91
Financial Ratios
Operating Profit Margin6.79%15.27%16.62%14.72%11.39%
Net Profit Margin4.72%11.66%11.62%10.83%8.31%
Earning Per Share (Diluted)9.0320.8722.6930.3219.14
Dividends Per ShareNANANANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.6.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI